NCT05281276 2024-12-20
Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC)
Taipei Medical University Shuang Ho Hospital
Phase 1 Terminated
Clinical Trials
3 trialsNCT02569489 2022-07-18
Dose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast Cancer
HUYABIO International, LLC.
Phase 1 Withdrawn
NCT02697552 2017-01-12
Safety Study of HBI-8000 in Japanese Patients With Non Hodgkin's Lymphoma
HUYABIO International, LLC.
Phase 1 Completed